Passenger Mutations Can Skew Results

Some genetically engineered mice harbor unwanted mutations that hitchhike alongside desired modifications, affecting experimental outcomes.

Written byKate Yandell
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, STEFANOPassenger mutations—unwanted alterations that accompany intentional genetic modifications—can confound experiments using certain types of transgenic mice. According to an analysis published today (July 7) in Immunity, passenger mutations are widespread in these animal models and can, in cases, significantly impact experimental results.

“This is a big problem. It affects us all,” said study coauthor Tom Vanden Berghe, a postdoc studying cell death in the lab of Peter Vandenabeele at the Vlaams Instituut voor Biotechnologie and Ghent University’s Inflammation Research Center in Belgium. “We made a web tool [where] people can put in their knockout [and] how many times they are backcrossed. Then they get a list of all possible passenger mutations.”

The new tool “empowers the scientific community to look a little closer” at the transgenic mice they are using, said Soren Warming, a senior scientist at Genentech who was not involved in the study.

Passenger mutations affect experiments using transgenic animals models called congenic mice, whose modified genetic material comes from a different genetic background than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies